The role of allergies (A) and tobacco exposure (T) in Obstructive Sleep Apnea Syndrome (OSAS) Type I/II (I/II) in children, and Sublingual Immunotherapy (SLIT) for the treatment of children with OSAS I/II with an Allergic Profile (AP)
Kalomoira Kefala (Ile-de-France, France), Philippe Guerin
Source: Sleep and Breathing Conference 2021
Disease area: Sleep and breathing disorders
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: